(Q31880890)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

D Vay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Parodi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Rolla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Mottaran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Vidali

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Bellomo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

Free Radical Biology and Medicine

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

277-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Circulating Antibodies Recognizing Oxidatively Modified Low-Density Lipoprotein in Children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Protein modification by lipid peroxidation products: formation of malondialdehyde-derived N(epsilon)-(2-propenol)lysine in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900469-X

7 January 2021

10.1016/S0891-5849(00)00469-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165874%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference